Cannabis and Psilocybin Measures Make History Across the United States

After an exciting Election Tuesday, we are delighted to announce the passage of several landmark measures to legalize cannabis and psychedelic use in Arizona, DC, Mississippi, Montana, New Jersey, Oregon, and South Dakota. Poll numbers leading up to voting day indicated bipartisan support for many of the measures, which indicates a widespread shift in public opinion. In fact, Arizona passed a measure that was quite similar to one that was proposed four years earlier, but failed by only 2,000 votes.

Let’s take a closer look at each jurisdiction, measure, and what we can expect in the implementation of each new law:

Arizona: Proposition 207 has passed, which allows adults 21 and older to possess, consume, or transfer up to 1 ounce of cannabis and create a regulatory system for the drug’s cultivation, sale, and testing.

District of Columbia: Initiative 81 has passed, which decriminalizes a wide range of psychedelics in the nation’s capital. Because DC is not a state and falls under congressional oversight, Initiative 81 will go into effect after a 30-day review period by federal lawmakers.

Mississippi: Initiative 65 has passed, which allows physicians to recommend medical cannabis for patients with any of 22 qualifying conditions, including cancer, multiple sclerosis, and post-traumatic stress disorder. The initiative would also permit the smoking of medical cannabis for the terminally ill and provide the legislature with the authority to create a regulatory framework.

Montana: Initiative 190 has passed, which allows adults over the age of 21 in the state to possess and buy cannabis for recreational use, establishes a cannabis tax, and allows people serving sentences for cannabis-related crimes to apply for resentencing or expungement.

New Jersey: Public Question 1 has passed, which amends the state constitution to legalize cannabis for adults 21 and older. The state commission overseeing the medical cannabis market will also regulate the recreational market.

Oregon: Measure 109 has passed, which legalized psilocybin, or psychedelic mushrooms. The legislature now has a 2 year period to determine how the drug will be related, as well as establish a regulatory body to oversee the qualifications for therapists to administer the drug.

South Dakota: Measure 26 and Amendment A have both passed, which establish a medical cannabis program and legalizes cannabis for all adults. Amendment A also requires the state legislature to adopt medical cannabis and hemp laws. By approving both of these measures at once, South Dakota was able to legalize medical and recreational cannabis in a single election.

While many of these measures only represent the first step to legalization, we are eager to help support our clients to prepare their businesses for expansion into these new and exciting markets. We are especially excited for opportunities that are emerging in Arizona and New Jersey. Read more about Arizona’s road to legalization below:

The most recent poll numbers showed growing support for the Smart and Safe Arizona Act, Arizona’s current ballot initiative to legalize recreational cannabis. One poll reported that 55 percent of likely voters favor the cannabis legalization initiative, while 37 percent oppose it. Another poll showed 56 percent support for the initiative among registered voters and 36 percent opposed. Both of these polls show at least a 5-percentage point increase from last month’s survey of registered voters. The legal cannabis measure demonstrated support from men, women, people from every geographic region of the state and voters under age 54.

Now that the measure has passed, Arizona will establish a cannabis licensing office and offer 30 new cannabis business licenses to increase the number of dispensaries to 160. It has been estimated that the recreational cannabis market in Arizona would generate approximately $341 million in the first year.

Check out our previous Arizona Update!

About Global Go  
Global Go provides sophisticated consulting services to the global cannabis and hemp industry.  In tandem with strategic allies around the world, Global Go serves clients throughout the world from offices in Bogota, Chicago, Johannesburg, London, Los Angeles, Mexico City, New York, Nicosia, Palm Springs, Phoenix, São Paulo, Silicon Valley, Toronto, and Zurich. Powered by a team of cannabis industry pioneers and world-class consultants, Global Go helps leading cannabis funds and companies assess and enter new markets; acquire assets; raise capital; launch new product lines; improve SOPs; comply with regulations; implement technology and security systems; find talent; diagnose and execute solutions to growth obstacles; and apply for cannabis licenses (with a 99% success rate on over 150 cannabis license applications across the United States).  Learn more at